Invention Grant
- Patent Title: Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
-
Application No.: US17251494Application Date: 2019-06-11
-
Publication No.: US11713327B2Publication Date: 2023-08-01
- Inventor: Fabian Dey , Buyu Kou , Haixia Liu , Hong Shen , Xiaoqing Wang , Weixing Zhang , Zhisen Zhang , Zhiwei Zhang , Wei Zhu
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agency: Genentech, Inc.
- Agent Richard G. A. Bone
- Priority: WO TCN2018090783 2018.06.12 EP 193919 2018.09.12 WO TCN2019082889 2019.04.16
- International Application: PCT/EP2019/065091 2019.06.11
- International Announcement: WO2019/238616A 2019.12.19
- Date entered country: 2020-12-11
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; C07D498/10
Abstract:
The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20210300947A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE Public/Granted day:2021-09-30
Information query
